[go: up one dir, main page]

AU3167993A - Ligands and binding partner for treatment and diagnosis of inflammatory conditions - Google Patents

Ligands and binding partner for treatment and diagnosis of inflammatory conditions

Info

Publication number
AU3167993A
AU3167993A AU31679/93A AU3167993A AU3167993A AU 3167993 A AU3167993 A AU 3167993A AU 31679/93 A AU31679/93 A AU 31679/93A AU 3167993 A AU3167993 A AU 3167993A AU 3167993 A AU3167993 A AU 3167993A
Authority
AU
Australia
Prior art keywords
ligands
diagnosis
treatment
binding partner
inflammatory conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31679/93A
Inventor
Jo Michelle Spencer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Publication of AU3167993A publication Critical patent/AU3167993A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU31679/93A 1991-12-19 1992-12-21 Ligands and binding partner for treatment and diagnosis of inflammatory conditions Abandoned AU3167993A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9126918 1991-12-19
GB919126918A GB9126918D0 (en) 1991-12-19 1991-12-19 Members of specific binding pairs;methods of their making and using

Publications (1)

Publication Number Publication Date
AU3167993A true AU3167993A (en) 1993-07-19

Family

ID=10706501

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31679/93A Abandoned AU3167993A (en) 1991-12-19 1992-12-21 Ligands and binding partner for treatment and diagnosis of inflammatory conditions

Country Status (3)

Country Link
AU (1) AU3167993A (en)
GB (1) GB9126918D0 (en)
WO (1) WO1993012248A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148251T3 (en) * 1993-03-10 2000-10-16 Cedars Sinai Medical Center METHODS FOR SELECTIVELY DETECTING ANTICYTOPLASM ANTIBODIES OF PERINUCLEAR NEUTROPHILS FROM ULCEROUS COLITIS OR PRIMARY SCLEROSANT COLANGITIS.
US5830675A (en) * 1993-03-10 1998-11-03 Cedars-Sinai Medical Center Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
US5681699A (en) * 1994-02-11 1997-10-28 Cedars-Sinai Medical Center Methods of diagnosing ulcerative colitis and Crohn's disease
US6884590B1 (en) 1994-02-11 2005-04-26 Cedars-Sinai Medical Center Methods of screening for ulcerative colitis and crohn's disease
US5738847A (en) * 1994-09-19 1998-04-14 The Regents Of The University Of California Anti-VH3-15 reagents and methods for their use
US5691151A (en) * 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
US20040248323A1 (en) 2003-06-09 2004-12-09 Protometrix, Inc. Methods for conducting assays for enzyme activity on protein microarrays
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
WO2014160883A1 (en) 2013-03-27 2014-10-02 Cedars-Sinai Medical Center Treating fibrosis and inflammation by inhibiting tl1a
EP3022295A4 (en) 2013-07-19 2017-03-01 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
KR102464372B1 (en) 2016-03-17 2022-11-04 세다르스-신나이 메디칼 센터 Methods of diagnosing inflammatory bowel disease through rnaset2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE114972T1 (en) * 1987-11-02 1994-12-15 Baylor College Medicine USE OF ICAM-1 OR ITS FUNCTIONAL DERIVATIVES TO TREAT NON-SPECIFIC INFLAMMATION.
US5147637A (en) * 1988-06-07 1992-09-15 The Rockefeller University Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma

Also Published As

Publication number Publication date
WO1993012248A1 (en) 1993-06-24
GB9126918D0 (en) 1992-02-19

Similar Documents

Publication Publication Date Title
AU3738293A (en) Compounds useful for treating allergic and inflammatory diseases
GR3036347T3 (en) Compounds useful for treating allergic and inflammatory diseases.
AU7336891A (en) Fitted mattress cover and method of making same
AU7905894A (en) Treatment of poultry
AU1532492A (en) Use of heterocyclic compounds for the treatment of inflammatory pain
AU584590B2 (en) Zinc complexes of hydroxypyrones and hydroxypyridones
AU642762B2 (en) Method of treating inflammatory bowel disease
AU4009795A (en) Heterocyclic compounds and their use
AU3167993A (en) Ligands and binding partner for treatment and diagnosis of inflammatory conditions
AU5543494A (en) Method and kit for cancer diagnosis
AU8192691A (en) Method of treatment and compositions therefore
AU2821295A (en) Compositions and methods for the treatment of tumors
AU1097192A (en) Treatment of particulate material
AU3574395A (en) Magnetic treatment of fluids
AU8574591A (en) Treatment of peptic ulcer
AU549565B2 (en) L (-) carnotine hydrochloride and l (-) carnotine inner salt
AU8879691A (en) Treatment of dispersions
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU8113091A (en) Method of treatment of allergic conjunctivitis
AU8864791A (en) Antibodies and methods for diagnosis and treatment of diabetes
AU6270794A (en) Treatment of allergic responses using mhc-peptide complexes
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AUPM836794A0 (en) Improved method and composition for the treatment of ulcers
AU9082698A (en) Treatment of inflammatory conditions
AU1736692A (en) Diagnosis and treatment of double stranded deficiency states